View Clinical Trial (Medical Research Study)
Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-37601(Clinical Trial 299638)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Johnson City |
|
State:
|
|
TN |
| Zip Code: |
|
37601 |
| Conditions: |
|
Gout |
| Purpose: |
|
This 24-week open-label extension study is designed to provide additional long-term safety
data up to a total of 1-year for patients rolling over from the core study, and to collect
further efficacy and tolerability data for all the patients, irrespective whether they have
an acute flare of gout or not. Patients will be treated on demand with canakinumab (ACZ885)
in this extension study.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Patients who completed the core study CACZ885H2251. A patient is defined as
completing the core study if he/she completed the study up to and including the last
visit (Visit 9).
- Patients who have signed a written informed consent before any trial procedure is
performed.
Exclusion Criteria:
- Patients for whom continuation in the extension 1 is not considered appropriate by
the treating physician.
- Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a
female after conception and until the termination of gestation, confirmed by a
positive pregnancy test (serum or urine).
Other protocol defined inclusion/exclusion criteria may apply |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|